Literature DB >> 12419310

Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction?

Giancarlo Aldini1, Marina Carini, Giangiacomo Beretta, Silvia Bradamante, Roberto Maffei Facino.   

Abstract

The aim of this study was to understand the mechanism of action through which carnosine (beta-alanyl-L-histidine) acts as a quencher of cytotoxic alpha,beta-unsaturated aldehydes, using 4-hydroxy-trans-2,3-nonenal (HNE) as a model aldehyde. In phosphate buffer solution (pH 7.4), carnosine was 10 times more active as an HNE quencher than L-histidine and N-acetyl-carnosine while beta-alanine was totally inactive; this indicates that the two constitutive amino acids act synergistically when incorporated as a dipeptide and that the beta-alanyl residue catalyzes the addition reaction of the histidine moiety to HNE. Two reaction products of carnosine were identified, in a pH-dependent equilibrium: (a) the Michael adduct, stabilized as a 5-member cyclic hemi-acetal and (b) an imine macrocyclic derivative. The adduction chemistry of carnosine to HNE thus appears to start with the formation of a reversible alpha,beta-unsaturated imine, followed by ring closure through an intra-molecular Michael addition. The biological role of carnosine as a quencher of alpha,beta-unsaturated aldehydes was verified by detecting carnosine-HNE reaction adducts in oxidized rat skeletal muscle homogenate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419310     DOI: 10.1016/s0006-291x(02)02545-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization.

Authors:  Miao Wang; Huafeng Fang; Xianlin Han
Journal:  Anal Chem       Date:  2012-04-24       Impact factor: 6.986

2.  Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium.

Authors:  Margaret-Ann M Nelson; Zachariah J Builta; T Blake Monroe; Jonathan A Doorn; Ethan J Anderson
Journal:  Amino Acids       Date:  2018-09-06       Impact factor: 3.520

3.  Dietary regulation of catabolic disposal of 4-hydroxynonenal analogs in rat liver.

Authors:  Qingling Li; Kristyen Tomcik; Shenghui Zhang; Michelle A Puchowicz; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2012-01-04       Impact factor: 7.376

4.  Urinary levels of the acrolein conjugates of carnosine are associated with inhaled toxicants.

Authors:  Timothy E O'Toole; Xiaohong Li; Daniel W Riggs; David J Hoetker; Ray Yeager; Pawel Lorkiewicz; Shahid P Baba; Nigel G F Cooper; Aruni Bhatnagar
Journal:  Inhal Toxicol       Date:  2020-11-12       Impact factor: 2.724

Review 5.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

Review 6.  Biogenic Aldehydes as Therapeutic Targets for Cardiovascular Disease.

Authors:  Margaret-Ann M Nelson; Shahid P Baba; Ethan J Anderson
Journal:  Curr Opin Pharmacol       Date:  2017-05-18       Impact factor: 5.547

7.  Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications.

Authors:  Zhengzhi Xie; Shahid P Baba; Brooke R Sweeney; Oleg A Barski
Journal:  Chem Biol Interact       Date:  2013-01-09       Impact factor: 5.192

8.  Carnosine protects cardiac myocytes against lipid peroxidation products.

Authors:  Jingjing Zhao; Dheeraj Kumar Posa; Vijay Kumar; David Hoetker; Amit Kumar; Smirthy Ganesan; Daniel W Riggs; Aruni Bhatnagar; Michael F Wempe; Shahid P Baba
Journal:  Amino Acids       Date:  2018-11-17       Impact factor: 3.520

9.  The stereochemical course of 4-hydroxy-2-nonenal metabolism by glutathione S-transferases.

Authors:  Larissa M Balogh; Arthur G Roberts; Laura M Shireman; Robert J Greene; William M Atkins
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

10.  N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.

Authors:  Mark A Babizhayev; Leslie Burke; Philip Micans; Stuart P Richer
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.